Philippe Marc team main activity is mining data to help selection of best compounds and companion bio-markers/diagnostics by Novartis Translational Medicine groups. Data from classical clinical and pre-clinical studies are blended with genomics, pharmacogenomics, transcriptomics, epi-genetics, digital devices data from animal and human. Final goal is to design better drugs with less side effects using translational medicine power.